APA (7th ed.) Citation

J, N., B, H., & U, G. (2025). Ubrogepant, erenumab, and eptinezumab antagonize positive inotropic effects of the calcitonin gene-related peptide in the isolated human atrium. Naunyn-Schmiedeberg's archives of pharmacology, 398(9), 11909. https://doi.org/10.1007/s00210-025-04029-7

Chicago Style (17th ed.) Citation

J, Neumann, Hofmann B, and Gergs U. "Ubrogepant, Erenumab, and Eptinezumab Antagonize Positive Inotropic Effects of the Calcitonin Gene-related Peptide in the Isolated Human Atrium." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 9 (2025): 11909. https://doi.org/10.1007/s00210-025-04029-7.

MLA (9th ed.) Citation

J, Neumann, et al. "Ubrogepant, Erenumab, and Eptinezumab Antagonize Positive Inotropic Effects of the Calcitonin Gene-related Peptide in the Isolated Human Atrium." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 9, 2025, p. 11909, https://doi.org/10.1007/s00210-025-04029-7.